PL339413A1 - Antagonistic vitronectin receptor - Google Patents
Antagonistic vitronectin receptorInfo
- Publication number
- PL339413A1 PL339413A1 PL98339413A PL33941398A PL339413A1 PL 339413 A1 PL339413 A1 PL 339413A1 PL 98339413 A PL98339413 A PL 98339413A PL 33941398 A PL33941398 A PL 33941398A PL 339413 A1 PL339413 A1 PL 339413A1
- Authority
- PL
- Poland
- Prior art keywords
- antagonistic
- vitronectin receptor
- vitronectin
- receptor
- antagonistic vitronectin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5983297P | 1997-09-24 | 1997-09-24 | |
| PCT/US1998/019949 WO1999015170A1 (en) | 1997-09-24 | 1998-09-24 | Vitronectin receptor antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL339413A1 true PL339413A1 (en) | 2000-12-18 |
Family
ID=22025570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98339413A PL339413A1 (en) | 1997-09-24 | 1998-09-24 | Antagonistic vitronectin receptor |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1017387A4 (xx) |
| JP (1) | JP2002528380A (xx) |
| KR (1) | KR20010024247A (xx) |
| CN (1) | CN1273529A (xx) |
| AU (1) | AU9577498A (xx) |
| BR (1) | BR9813208A (xx) |
| CA (1) | CA2303846A1 (xx) |
| HU (1) | HUP0003949A2 (xx) |
| IL (1) | IL135189A0 (xx) |
| NO (1) | NO20001514L (xx) |
| PL (1) | PL339413A1 (xx) |
| TR (1) | TR200000792T2 (xx) |
| WO (1) | WO1999015170A1 (xx) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU747503B2 (en) | 1999-02-03 | 2002-05-16 | Merck & Co., Inc. | Benzazepine derivatives as alpha-V integrin receptor antagonists |
| US6514964B1 (en) * | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
| CA2419255A1 (en) * | 2000-08-29 | 2002-03-07 | Ish Kumar Khanna | Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| US6531494B1 (en) | 2001-08-29 | 2003-03-11 | Pharmacia Corporation | Gem-substituted αvβ3 antagonists |
| CZ2003459A3 (cs) * | 2000-08-30 | 2003-09-17 | Pharmacia Corporation | GEM-substituované antagonisty integrinu alfa v beta 3 |
| AU2002316855B2 (en) | 2001-04-24 | 2008-03-13 | Merck Patent Gmbh | Combination therapy using anti-angiogenic agents and TNFalpha |
| KR20040058229A (ko) | 2001-10-22 | 2004-07-03 | 더 스크립스 리서치 인스티튜트 | 항체 표적화 화합물 |
| UA87854C2 (xx) | 2004-06-07 | 2009-08-25 | Мерк Энд Ко., Инк. | N-(2-бензил)-2-фенілбутанаміди як модулятори рецептора андрогену$n-(2-бензил)-2-фенилбутанамиды как модуляторы рецептора андрогена |
| ES2425396T3 (es) | 2006-01-18 | 2013-10-15 | Merck Patent Gmbh | Terapia específica usando ligandos de integrinas para el tratamiento del cáncer |
| DK2101805T3 (da) | 2007-01-18 | 2013-01-21 | Merck Patent Gmbh | Integrinligander til anvendelse i behandling af cancer |
| ES2428896T3 (es) * | 2007-11-16 | 2013-11-12 | Ube Industries, Ltd. | Compuesto de benzacepinona |
| WO2009111679A2 (en) * | 2008-03-06 | 2009-09-11 | Smithkline Beecham Corporation | Process |
| US8518927B2 (en) | 2009-02-10 | 2013-08-27 | The Scripps Research Institute | Chemically programmed vaccination |
| US20120095215A1 (en) | 2009-03-30 | 2012-04-19 | Ube Industries, Ltd. | Medical composition for treatment or prophylaxis of eye diseases |
| JP5572996B2 (ja) * | 2009-05-15 | 2014-08-20 | 宇部興産株式会社 | ベンズアゼピノン化合物を有効成分として含有する医薬 |
| JP2012528079A (ja) | 2009-05-25 | 2012-11-12 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌を治療するためのインテグリンリガンドの連続投与 |
| CN103864765B (zh) * | 2014-03-05 | 2016-02-10 | 天津药物研究院 | 含有五元杂环的苯并氮杂卓类衍生物、其制备方法和用途 |
| US10328082B2 (en) | 2014-05-30 | 2019-06-25 | Pfizer Inc. | Methods of use and combinations |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA955391B (en) * | 1994-06-29 | 1996-02-09 | Smithkline Beecham Corp | Vitronectin receptor antagonists |
| UA60311C2 (uk) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція |
| JP2001501951A (ja) * | 1996-10-07 | 2001-02-13 | スミスクライン・ビーチャム・コーポレイション | 骨形成刺激方法 |
-
1998
- 1998-09-24 JP JP2000512539A patent/JP2002528380A/ja not_active Withdrawn
- 1998-09-24 TR TR2000/00792T patent/TR200000792T2/xx unknown
- 1998-09-24 WO PCT/US1998/019949 patent/WO1999015170A1/en not_active Application Discontinuation
- 1998-09-24 BR BR9813208-3A patent/BR9813208A/pt not_active Application Discontinuation
- 1998-09-24 IL IL13518998A patent/IL135189A0/xx unknown
- 1998-09-24 EP EP98949454A patent/EP1017387A4/en not_active Withdrawn
- 1998-09-24 HU HU0003949A patent/HUP0003949A2/hu unknown
- 1998-09-24 CA CA002303846A patent/CA2303846A1/en not_active Abandoned
- 1998-09-24 PL PL98339413A patent/PL339413A1/xx unknown
- 1998-09-24 CN CN98809495A patent/CN1273529A/zh active Pending
- 1998-09-24 KR KR1020007003088A patent/KR20010024247A/ko not_active Application Discontinuation
- 1998-09-24 AU AU95774/98A patent/AU9577498A/en not_active Abandoned
-
2000
- 2000-03-23 NO NO20001514A patent/NO20001514L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1273529A (zh) | 2000-11-15 |
| BR9813208A (pt) | 2000-08-22 |
| NO20001514D0 (no) | 2000-03-23 |
| KR20010024247A (ko) | 2001-03-26 |
| JP2002528380A (ja) | 2002-09-03 |
| TR200000792T2 (tr) | 2000-09-21 |
| CA2303846A1 (en) | 1999-04-01 |
| WO1999015170A1 (en) | 1999-04-01 |
| EP1017387A1 (en) | 2000-07-12 |
| NO20001514L (no) | 2000-03-23 |
| HUP0003949A2 (hu) | 2001-10-28 |
| EP1017387A4 (en) | 2004-08-18 |
| IL135189A0 (en) | 2001-05-20 |
| AU9577498A (en) | 1999-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL332674A1 (en) | Antagonistic receptor of vitronectin | |
| EP1000031A4 (en) | VITRONECTIN RECEPTOR ANTAGONISTS | |
| EP1047425A4 (en) | INTEGRIN RECEPTOR ANTAGONISTS | |
| ZA9896B (en) | Vitronectin receptor antagonists | |
| EP0767792A4 (en) | VITRONECTIN RECEPTOR ANTAGONISTS | |
| ZA955391B (en) | Vitronectin receptor antagonists | |
| EP1007051A4 (en) | INTEGRIN RECEPTOR ANTAGONISTS | |
| PL339413A1 (en) | Antagonistic vitronectin receptor | |
| PL339414A1 (en) | Antagonistic vitronectin receptor | |
| IL135028A0 (en) | Vitronectin receptor antagonists | |
| PL342881A1 (en) | Vitronectin receptor antagonists | |
| EP1027337A4 (en) | Integrin receptor Antagonist | |
| EG24025A (en) | Vitronectin receptor antagonist | |
| EP0973800A4 (en) | NEW RECEIVER | |
| IL141163A0 (en) | Vitronectin receptor antagonists | |
| ZA988562B (en) | Vitronectin receptor antagonists | |
| SI0957917T1 (sl) | Antagonisti receptorja vitronektina | |
| GB9810882D0 (en) | Vitronectin receptor antagonists | |
| GB9815803D0 (en) | Vitronectin receptor antagonists | |
| GB9812686D0 (en) | Vitronectin receptor antagonists | |
| GB9811295D0 (en) | Vitronectin receptor antagonists | |
| GB9810892D0 (en) | Vitronectin receptor antagonists | |
| GB9810182D0 (en) | Vitronectin receptor antagonists | |
| GB9807384D0 (en) | Vitronectin receptor antagonists | |
| GB9807382D0 (en) | Vitronectin receptor antagonists |